Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 177

1.

Sexual risk behaviour of Canadian participants in the first efficacy trial of a preventive HIV-1 vaccine.

Lampinen TM, Chan K, Remis RS, Merid MF, Rusch M, Vincelette J, Logue K, Popovic V, Alary M, Schechter MT, Hogg RS.

CMAJ. 2005 Feb 15;172(4):479-83.

2.

Partner-specific sexual behavioral differences between phase 3 HIV vaccine efficacy trial participants and controls: Project VISION.

Whittington WL, Morris M, Buchbinder SP, McKirnan DJ, Mayer KH, Para MF, Bartholow BN, Celum CL.

J Acquir Immune Defic Syndr. 2006 Oct 1;43(2):234-8.

PMID:
16951646
3.

Acceptability of HIV vaccine trials in high-risk heterosexual cohorts in Mombasa, Kenya.

Jackson DJ, Martin HL Jr, Bwayo JJ, Nyange PM, Rakwar JP, Kashonga F, Mandaliya K, Ndinya-Achola JO, Kreiss JK.

AIDS. 1995 Nov;9(11):1279-83.

PMID:
8561982
4.

HIV sexual risk behavior over 36 months of follow-up in the world's first HIV vaccine efficacy trial.

Bartholow BN, Buchbinder S, Celum C, Goli V, Koblin B, Para M, Marmor M, Novak RM, Mayer K, Creticos C, Orozco-Cronin P, Popovic V, Mastro TD; VISION/VAX004 Study Team..

J Acquir Immune Defic Syndr. 2005 May 1;39(1):90-101.

PMID:
15851919
5.

Risk behavior for HIV infection in participants in preventive HIV vaccine trials: a cautionary note.

Chesney MA, Chambers DB, Kahn JO.

J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Dec 1;16(4):266-71.

PMID:
9402073
6.

Feasibility of a preventive HIV-1 vaccine cohort among persons attending sexually transmitted disease clinics in Thailand.

Markowitz LE, Sirisopana N, Charonwatanachokchai A, Julvanichpong W, Siraprapasiri T, Palanuvej T, Siriwongrangsun P, Tungsakul V, Pumratana K, Chitwarakorn A, Michael RA, Brown AE.

J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Apr 15;20(5):488-94.

PMID:
10225232
7.

HIV vaccine efficacy trial participation: men who have sex with men's experiences of risk reduction counselling and perceptions of risk behaviour change.

Guest G, McLellan-Lemal E, Matia DM, Pickard R, Fuchs J, McKirnan D, Neidig JL.

AIDS Care. 2005 Jan;17(1):46-57.

PMID:
15832833
9.

Willingness to participate and enroll in a phase 3 preventive HIV-1 vaccine trial.

O'Connell JM, Hogg RS, Chan K, Strathdee SA, McLean N, Martindale SL, Willoughby B, Remis R.

J Acquir Immune Defic Syndr. 2002 Dec 15;31(5):521-8.

PMID:
12473841
10.

Motivations for participating in an HIV vaccine efficacy trial.

Colfax G, Buchbinder S, Vamshidar G, Celum C, McKirnan D, Neidig J, Koblin B, Gurwith M, Bartholow B.

J Acquir Immune Defic Syndr. 2005 Jul 1;39(3):359-64.

PMID:
15980699
11.
12.

Sexual risk behaviors of HIV-positive, HIV-negative, and serostatus-unknown Black men who have sex with men and women.

Lauby JL, Millett GA, LaPollo AB, Bond L, Murrill CS, Marks G.

Arch Sex Behav. 2008 Oct;37(5):708-19. doi: 10.1007/s10508-008-9365-6.

PMID:
18521734
13.

HIV testing outside of the study among men who have sex with men participating in an HIV vaccine efficacy trial.

Gust DA, Wiegand RE, Para M, Chen RT, Bartholow BN.

J Acquir Immune Defic Syndr. 2009 Oct 1;52(2):294-8. doi: 10.1097/QAI.0b013e3181ab6e93.

PMID:
19574927
14.
15.

Willingness to participate in HIV vaccine trials among HIV-negative gay men in Sydney, Australia.

Van de Ven P, Mao L, Crawford J, Prestage G, Grulich A, Kaldor J, Kippax S.

Int J STD AIDS. 2005 Apr;16(4):314-7.

PMID:
15899086
16.

Human immunodeficiency virus incidence and risk behavior in the 'Projeto Rio': results of the first 5 years of the Rio de Janeiro open cohort of homosexual and bisexual men, 1994-98.

Sutmöller F, Penna TL, de Souza CT, Lambert J; Oswaldo Cruz Foundation STD/HIV Prevention Group..

Int J Infect Dis. 2002 Dec;6(4):259-65.

PMID:
12718818
17.

Knowledge of sexual partner's HIV serostatus and serosorting practices in a California population-based sample of men who have sex with men.

Xia Q, Molitor F, Osmond DH, Tholandi M, Pollack LM, Ruiz JD, Catania JA.

AIDS. 2006 Oct 24;20(16):2081-9.

PMID:
17053354
18.

Condom use rather than serosorting explains differences in HIV incidence among men who have sex with men.

Van der Bij AK, Kolader ME, de Vries HJ, Prins M, Coutinho RA, Dukers NH.

J Acquir Immune Defic Syndr. 2007 Aug 15;45(5):574-80.

PMID:
17554214
20.

HIV is hyperendemic among men who have sex with men in San Francisco: 10-year trends in HIV incidence, HIV prevalence, sexually transmitted infections and sexual risk behaviour.

Scheer S, Kellogg T, Klausner JD, Schwarcz S, Colfax G, Bernstein K, Louie B, Dilley JW, Hecht J, Truong HM, Katz MH, McFarland W.

Sex Transm Infect. 2008 Nov;84(6):493-8. doi: 10.1136/sti.2008.031823.

PMID:
19028954
Items per page

Supplemental Content

Support Center